NRx Pharmaceuticals, Inc. (NRXP)

NASDAQ: NRXP · Real-Time Price · USD

3.440

+0.010 (0.29%)

At close: Aug 18, 2026, 4:00 PM EDT

3.316

-0.124 (-3.61%)

After-hours: Aug 18, 2026, 7:56 PM EDT

NRx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.69	7.8	1.44	4.6	20.05	27.61
Cash & Short-Term Investments	26.69	7.8	1.44	4.6	20.05	27.61
Cash Growth	817.05%	440.33%	-68.60%	-77.09%	-27.35%	1384.94%
Accounts Receivable	0.21	0.16	-	-	-	-
Other Receivables	-	-	-	0.01	0.01	-
Receivables	0.21	0.16	-	0.01	0.01	-
Prepaid Expenses	2.27	0.59	1.04	1.41	3.77	4.6
Other Current Assets	-	0.34	0.82	0.87	1.97	0.51
Total Current Assets	29.16	8.89	3.3	6.88	25.8	32.71
Property, Plant & Equipment	1.75	0.7	0.01	-	-	-
Long-Term Investments	0.4	0.4	-	-	-	-
Goodwill	1.79	1.79	-	-	-	-
Other Intangible Assets	0.83	0.93	-	-	-	-
Other Long-Term Assets	0.22	0.25	0.34	0.43	0.02	0.02
Total Assets	34.16	12.96	3.65	7.32	25.82	32.73
Accounts Payable	3.15	4.27	4.13	4.63	2.08	3.69
Accrued Expenses	11.8	5.62	6.13	5.24	5.77	2.84
Current Portion of Long-Term Debt	-	-	1.25	9.16	7.7	0.52
Current Portion of Leases	0.38	0.32	-	-	-	-
Other Current Liabilities	18.55	18.37	10.35	0.02	0.04	4.87
Total Current Liabilities	33.87	28.58	21.86	19.05	15.59	11.92
Long-Term Debt	-	-	5.01	-	2.82	-
Long-Term Leases	0.46	0.32	-	-	-	-
Total Liabilities	34.33	28.89	26.87	19.05	18.41	11.92
Common Stock	0.04	0.03	0.02	0.01	0.07	0.06
Additional Paid-In Capital	324.63	290.93	255.04	241.41	230.34	203.99
Retained Earnings	-324.85	-306.9	-278.27	-253.15	-223	-183.24
Comprehensive Income & Other	-	-	-	-0	-	-
Total Common Equity	-0.17	-15.94	-23.22	-11.74	7.41	20.81
Shareholders' Equity	-0.17	-15.94	-23.22	-11.73	7.41	20.81
Total Liabilities & Equity	34.16	12.96	3.65	7.32	25.82	32.73
Total Debt	0.83	0.63	6.26	9.16	10.53	0.52
Net Cash (Debt)	25.85	7.17	-4.81	-4.57	9.53	27.09
Net Cash Growth	-	-	-	-	-64.82%	2450.57%
Net Cash Per Share	0.85	0.33	-0.45	-0.60	1.45	5.77
Filing Date Shares Outstanding	43.3	33.03	16.92	9.45	7.06	6.66
Total Common Shares Outstanding	43.16	31.7	14.59	8.27	6.54	5.88
Working Capital	-4.72	-19.69	-18.56	-12.16	10.21	20.79
Book Value Per Share	-0.00	-0.50	-1.59	-1.42	1.13	3.54
Tangible Book Value	-2.8	-18.66	-23.22	-11.74	7.41	20.81
Tangible Book Value Per Share	-0.06	-0.59	-1.59	-1.42	1.13	3.54
Machinery	-	0.09	0.03	-	-	-

SEC Filings: 10-K · 10-Q